Szemészet, 2012 (149. évfolyam, 1-4. szám)

2012-07-01 / 2. szám

Bacterial keratitis

Irodalom

1. Afshari NA, Ma JJK, Duncan SM, et a I. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis. Journal of Ocular Pharmacology and Therapeutics 2008 24: 217-223.

2. American Academy of Ophthalmology. Cornea/External Disease Panel. Preferred practice Pattern Guidelines. Bacterial keratitis - Limited revision. San Francisco CA: American Academy of Ophthalmology; 2011.

3. Anwar HM, El-Danasoury AM, Hashem AN. Corneal collagen crosslinking in the treatment of infectious keratitis. Clinical Ophthalmology 2011; 5: 1277-1280.

4. Barletta JR Angella G, Balch КС, et a I. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Investigative Ophthalmology and Visual Science 1996; 37: 20-28.

5. Basak SK, Basak S, Mohanta A, et a I. Epidemiological and microbiological diagnosis of suppurative keratitis in Gangetic West Bengal, eastern India. Indian Journal of Ophthalmology 2005; 53: 17-22.

6. Baum J, Barza M. Topical vs. subconjunctival treatment of bacterial corneal ulcers. Ophthalmology 1983; 90: 162-168.

7. Behrens-Baumann W, Pleyer U. Therapy and prognosis of bacterial keratitis (Therapie und prognose der bakteriellen keratitis). Ophthalmologe 2007; 104: 15-20.

8. Böhm MRR, Prokosch V, Mérté RL, et al. Microbiological analysis in contact lens-associated keratits (Bakterielles Spektrum der kontaktlinsenassoziierten Keratitis). Klinische Monatsblatter für Augenheilkunde 2011; 228: 808-814.

9. Cho R Conway R, Ching KK. Current contact lens practice in Hong Kong. Clinical and Experimental Optometry 1994; 77: 24-32.

10. Dahlgren MA, Lingappan A. The clinical diagnosis of microbial keratitis. Am J Ophthalmol 2007; 143: 940-944.

11. Edelstein SL, Wichiensin R Huang AJW. Bacterial keratitis. Chapter 77, Section 4. Cornea 3rd ed. Philadelphia: Elsevier Mosby; 2011.

12. Feilmeier MR, Sivaraman KR, Oliva M, et al. Etiologic diagnosis of corneal ulceration at a Tertiary Eye Center in Kathmandu, Nepal. Cornea 2010; 29: 1380-1385.

13. Gicquel J J, Bejjani RA, Ellies R et a I. Amniotic membrane transplantation in severe bacterial keratitis. Cornea 2007; 26: 27-33.

14. Hindman HB, Patel SB, Jun AS.Rationale for Adjunctive Topical Corticosteroids in Bacterial Keratitis. Arch Ophthalmol 2009; 127: 97-102.

15. Ibrahim YW, Boase DL, Cree IA. Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. British Journal of Ophthalmology 2009; 93: 1319-24.

16. Iseli HR Thiel MA, Hafezi E et al. Ultraviolet a/riboflavin corneal crosslinking for infectious keratitis associated with corneal melts. Cornea 2008; 27: 590-594.

17. Jeng BH, Gritz DC, Kumar AB, et al. Epidemiology of ulcerative keratitis in Northern California. Archives of Ophthalmology 2010; 128: 1022-1028.

18. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology 1981; 88: 814-20.

19. Kunimoto DY, Sharma S, Garg R Rao G. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 1999; 106: 80-85.

20. Kupferman A, Leibowitz HM. Quantitation of bacterial infection and antibiotic effect in the cornea. Archives of Ophthalmology 1976; 94: 1981-1984.

21. Kupferman A, Leibowitz HM. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis. Archives of Ophthalmology 1979; 97: 1699-1702.

22. Labbé A, Khammari C, Dupas B, et al. Contribution of in vivo confocal microscopy to the diagnosis and management of infectious keratitis. Ocular Surface 2009; 7: 41-52.

23. Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea 2010; 29: 1353-1358.

24. Makdoumi K, Mortensen J, Sorkhabi 0, et al. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology 2011. 1-8.

25. McLeod SD. Bacterial keratitis. Section 6, Chapter 4.12. Ophthalmology, 3d ed. Philadelphia: Elsevier Mosby; 2009.

26. RightDiagnosis.com. Age-related macular degeneration Available from:

http:// www.rightdiagnosis.com/a/age_related_macular_

degeneration/stats.htm.

27. Seal DV, Kirkness CM, Bennett HG, et al.Population-based cohort study of microbial keratitis in Scotland: incidence and features. Cont Lens Anterior Eye 1999; 22: 49-57.

28. Shah A, Sachdev A, Coggon D, Hossain R Geographic variations in microbial keratitis: An analysis of the peer-reviewed literature. British Journal of Ophthalmology 2011; 95: 762-767.

29. Siatiri H, Moghimi S, Malihi M, Khodabande A. Use of sealant (HFG) in corneal perforations. Cornea 2008; 27: 988-991.

30. Sii E Lee GA. Fibrin glue in the management of corneal melt. Clin Experiment Ophthalmol 2005; 33: 532-4.

31. Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: The steroids for corneal ulcers trial (SCUT). Archives of Ophthalmology 2012; 130: 143-150.

32. Subrayan V, Peyman M, Lek Yap S, et al. Assessment of polymerase chain reaction in the detection of pseudomonas aeruginosa in contact lens-induced severe infectious keratitis. Eye and Contact Lens 2010; 36: 201-203.

33. Szentmáry N, Goebels S, Bischoff M, Seitz B. Photodynamic therapy for infectious keratitis. Photodynamische Therapie bei infektiöser Keratitis 2012; 109: 165-170.

34. Vieira AC, MJ. M. Conjunctival Flaps. Part X., Section 2 - Conjunctival Surgery Chapter 145, Cornea 3rd ed. Philadelphia: Mosby Elsevier; 2011.

35. Willoughby CE, Batterbury M, Kaye SB. Collagen Corneal Shields. Survey of Ophthalmology 2002; 47: 174-182.

36. Yeh DL, Stinnett SS, Afshari NA. Analysis of Bacterial Cultures in InfOectious Keratitis, 1997 to 2004. American Journal of Ophthalmology 2006; 142: 1066-1068.

Dn Imre László

1083 Budapest, Vili. Tömő u.25-29., E-mail: imrelaszlo@pannonmail.hu

Levelezési cím